These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 26055036)
1. [Inability to walk in a 41-year-old man]. Karaa-Zbidi N; Damade R; Lhote F Rev Med Interne; 2016 Jan; 37(1):62-5. PubMed ID: 26055036 [No Abstract] [Full Text] [Related]
2. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23. Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099 [No Abstract] [Full Text] [Related]
3. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic]. Westerberg PA; Linde T; Ljunggren O Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430 [No Abstract] [Full Text] [Related]
4. Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1. Sahoo SK; Kushwaha P; Bharti N; Khedgikar V; Trivedi R; Agrawal V; Ahmad N; Zaidi G; Pal L; Ito N; Bhatia E Bone; 2019 Dec; 129():115055. PubMed ID: 31476437 [TBL] [Abstract][Full Text] [Related]
5. Oncogenous osteomalacia. Ghosh S; Sinha R; Bandyopadhyay R; Malhotra M J Cancer Res Ther; 2009; 5(3):210-2. PubMed ID: 19841566 [TBL] [Abstract][Full Text] [Related]
6. A Case of Hypophosphatemia due to Oncogenic Osteomalacia in a Patient with Natural Killer T-Cell Lymphoma. Zheng G; Kanduri SR; Canterbury JP; Nguyen T; Velez JCQ Kidney Blood Press Res; 2021; 46(5):647-651. PubMed ID: 34293749 [TBL] [Abstract][Full Text] [Related]
7. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature. Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740 [TBL] [Abstract][Full Text] [Related]